Amphastar Pharmaceuticals Total Long-Term Assets 2012-2024 | AMPH
Amphastar Pharmaceuticals total long-term assets from 2012 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
Amphastar Pharmaceuticals Annual Total Long-Term Assets
(Millions of US $) |
| 2023 |
$1,023 |
| 2022 |
$364 |
| 2021 |
$353 |
| 2020 |
$352 |
| 2019 |
$332 |
| 2018 |
$293 |
| 2017 |
$263 |
| 2016 |
$244 |
| 2015 |
$214 |
| 2014 |
$191 |
| 2013 |
$166 |
| 2012 |
$152 |
| 2011 |
$ |
| 2009 |
$0 |
Amphastar Pharmaceuticals Quarterly Total Long-Term Assets
(Millions of US $) |
| 2024-09-30 |
$999 |
| 2024-06-30 |
$1,009 |
| 2024-03-31 |
$1,019 |
| 2023-12-31 |
$1,023 |
| 2023-09-30 |
$1,002 |
| 2023-06-30 |
$994 |
| 2023-03-31 |
$366 |
| 2022-12-31 |
$364 |
| 2022-09-30 |
$342 |
| 2022-06-30 |
$347 |
| 2022-03-31 |
$352 |
| 2021-12-31 |
$353 |
| 2021-09-30 |
$348 |
| 2021-06-30 |
$355 |
| 2021-03-31 |
$346 |
| 2020-12-31 |
$352 |
| 2020-09-30 |
$337 |
| 2020-06-30 |
$333 |
| 2020-03-31 |
$326 |
| 2019-12-31 |
$332 |
| 2019-09-30 |
$317 |
| 2019-06-30 |
$317 |
| 2019-03-31 |
$315 |
| 2018-12-31 |
$293 |
| 2018-09-30 |
$286 |
| 2018-06-30 |
$282 |
| 2018-03-31 |
$276 |
| 2017-12-31 |
$263 |
| 2017-09-30 |
$261 |
| 2017-06-30 |
$250 |
| 2017-03-31 |
$244 |
| 2016-12-31 |
$244 |
| 2016-09-30 |
$239 |
| 2016-06-30 |
$227 |
| 2016-03-31 |
$222 |
| 2015-12-31 |
$214 |
| 2015-09-30 |
$196 |
| 2015-06-30 |
$195 |
| 2015-03-31 |
$194 |
| 2014-12-31 |
$191 |
| 2014-09-30 |
$186 |
| 2014-06-30 |
$183 |
| 2014-03-31 |
$168 |
| 2013-12-31 |
$166 |
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
$232 |
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.142B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
